Residual Telomerase Activity: A Marker of Cell Survival after Exposure to Gamma Radiation in Vitro

Anticancer Research

Volumn 23, Issue 6 C, 2003, Pages 4561-4569

  Turriziani, Mario ^a   Di Giacomo, Anna Maria ^a   Cardillo, Anna ^a   Torino, Francesco ^a   Tentori, Lucio ^a   Nasuti, Paola ^a   Massara, Maria Chiara ^a   Roselli, Mario ^a,b   Bonmassar, Enzo ^a   De Vecchis, Liana ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Lymphocytes; Oncology; Radiation; Radiosensitivity; Telomerase

Indexed keywords

BIOLOGICAL MARKER; CYTOTOXIC AGENT; PHYTOHEMAGGLUTININ; TELOMERASE;

ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL SURVIVAL; CELL VIABILITY; CLONOGENIC ASSAY; CONTROLLED STUDY; ENZYME ACTIVITY; GAMMA RADIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IONIZING RADIATION; LEUKEMIA CELL LINE; MONITORING; MONONUCLEAR CELL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIOSENSITIVITY; TUMOR GROWTH;

APOPTOSIS; CELL SURVIVAL; FLOW CYTOMETRY; GAMMA RAYS; HUMANS; JURKAT CELLS; LEUKEMIA, T-CELL; LEUKOCYTES, MONONUCLEAR; PHYTOHEMAGGLUTININS; REFERENCE VALUES; TELOMERASE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 10744228437     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion A, Chiu CP, Adams RR, Chang E, Allsopp RC and Villeponteau B: The RNA component of human telomerase. Science 269: 1236-1241, 1995.
2. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviellow GM, Wrigth WE, Weinrich SL and Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
3. Broccoli D, Young JW and de Lange T: Telomerase activity in normal and malignant hematopoietic cells and in hematological malignancies. Proc Natl Acad Sci USA 92: 9082-9086, 1995.
4. Counter CM, Gupta J, Harley CB, Leber B and Bacchetti S: Telomerase activity in normal leucocytes and hematological malignancies. Blood 85: 2315-2320, 1995.
5. Langford LA, Piatyszek MA, Xu R, Schold Jr SC and Shay JW: Telomerase activity in human brain tumors. Lancet 346: 1267-1268, 1995.
6. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakamy Y, Kodama T, Piatyszek MA, Shay JW and Matsuura Y: Telomerase activity in gastric cancer. Cancer Res 55: 3258-3262, 1995.
7. Hiyama E, Kodama T, Shinbara K, Iwao T, Itoh M, Hiyama K, Shay JW, Matsuura Y and Yokoyama T: Telomerase activity is detected in pancreatic cancer but not in benign tumors. Cancer Res 57: 326-331, 1997.
8. Hiyama E, Gollahon L, Kataoka T, Kuroi K, Yokoyama T, Gazdar AF, Hiyama K, Piatyszek MA and Shay JW: Telomerase activity in human breast tumors. J Natl Cancer Inst 88: 116-122, 1996.
9. Lin Y, Miyamoto H, Fuijnami K, Uemura H, Hosaka M, Iwasaki Y and Kubota Y: Telomerase activity in human bladder cancer. Clin Cancer Res 2: 929-932, 1996.
10. Faraoni I, Turriziani M, Graziani G, De Vecchis L and Bonmassar E: Telomerase as a marker of tumor cell viability: a new approach for in vitro chemosensitivity assays? J Exp Clin Cancer Res 15: 311-312, 1996.
11. Faraoni I, Turriziani M, Bonmassar E, De Vecchis L and Graziani G: Development of a novel in vitro chemosensitivity assay: telomerase as a possible marker of tumor cell survival. J Chemother 8: 394-398, 1996.
12. Faraoni I, Turriziani M, De Vecchis L, Laurenza M, Macchini V, Baliva G, Bonmassar E and Graziani G: In vitro chemosensitivity of neoplastic cells: telomerase as a possible marker of tumor cell survival. Chron Derm 6: 161-168, 1996.
13. Faraoni I, Turriziani M, Masci G, De Vecchis L, Shay JW, Bonmassar E and Graziani G. Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro. Clin Cancer Res 3: 579-585, 1997.
14. Faraoni I, Graziani G, Turriziani M, Masci G, Testori A, Veronesi U and Bonmassar E: Suppression of telomerase activity as an indicator of drug-induced cytotoxicity against cancer cells: in vitro studies with fresh human tumor samples. Lab Invest 79: 993-1005, 1999.
15. Faraoni I, Bonmassar E and Graziani G. Clinical applications of telomerase in cancer treatment. Drug Resist Updat 3: 161-170, 2000.
16. Vigorito E, Plaza S, Mir L, Mongay L, Vinas O, Serra-Pages C and Vives J: Contributions of p53 and PMA to gamma-irradiation induced apoptosis in Jurkat cells. Hematol Cell Ther 41: 153-61, 1999.
17. Hansen MB, Nielsen SE and Berg K: Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119: 203-210, 1989.
18. Piatyszek MA, Kim NW, Weinrich SL, Hiyama K, Hiyama E, Wright WE and Shay JW: Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci 17: 1-15, 1995.
19. Hamburger AW and Salmon SE: Primary bioassay of human myeloma stem cell. J Clin Invest 60: 846-854, 1977.
20. Hamburger AW and Salmon SE: Primary bioassay of human tumor stem cell. Science (Wash. DC) 197: 461-463, 1978.
21. Hamburger AW, Salmon, SE, Kim MB, Trent JM, Soehnlen BJ, Alberts DS and Schmidt HJ: Direct cloning of human ovarian carcinoma cells in agar. Cancer Res 38: 3438-3444, 1978.
22. Von Hoff DD, Clark GM, Stogdill BJ, Sarosdy MF, O'Brien MT, Casper JT, Mattox DE, Page CP, Cruz AB and Sandbach JF: Prospective clinical trial of a human tumor cloning system. Cancer Res 43: 1926-1931, 1983.
23. Nakano H, Kohara M and Shinohara K: Evaluation of the relative contribution of p53-mediated pathway in X-ray-induced apoptosis in human leukemic MOLT-4 cells by transfection with a mutant p53 gene at different expression levels. Cell Tissue Res 306: 101-106, 2001.
24. Horie K, Kubo K and Yonezawa M: p53 dependency of radio-adaptive responses in endogenous spleen colonies and peripheral blood-cell counts in C57BL mice. J Radiat Res 43: 353-360, 2002.
25. Wang B: Involvement of p53-dependent apoptosis in radiation teratogenesis and in the radioadaptive response in the late organogenesis of mice. J Radiat Res 42: 1-10, 2001.
26. Lin Z, Lim S, Viani MA, Sapp M and Lim MS: Down-regulation of telomerase activity in malignant lymphomas by radiation and chemotherapeutic agents. Am J Pathol 159: 711-719, 2001.
27. Balasubramanian S, Kim KH, Ahmad N and Mukhtar H: Activation of telomerase and its association with G1-phase of the cell cycle during UVB-induced skin tumorigenesis in SKH-1 hairless mouse. Oncogene 18: 1297-1302, 1999.
28. Kim HR, Kim YJ, Kim HJ, Kim SK and Lee JH: Change of telomerase activity in rectal cancer with chemoradiation therapy. J Korean Med Sci 15: 167-172, 2000.
29. Sawant SG, Gregoire V, Dhar S, Umbricht CB, Cvilic S, Sukumar S and Pandita TK: Telomerase activity as a measure for monitoring radiocurability of tumor cells. FASEB J 13: 1047-1054, 1999.
30. Hande MP, Lansdorp PM and Natarajan AT: Induction of telomerase activity by in vivo X-irradiation of mouse splenocytes and its possible role in chromosome healing. Mutat Res 404: 205-214, 1998.
31. Hyeon OJ, Hande MP, Lansdorp PM and Natarajan AT: Induction of telomerase activity and chromosome aberrations in human tumour cell lines following X-irradiation. Mutat Res 40: 121-131, 1998.
32. Leteurtre F, Li X, Gluckman E and Carosella ED: Telomerase activity during the cell cycle and in gamma-irradiated hematopoietic cells. Leukemia 11: 1681-1689, 1997.
33. Akiyama M, Horiguchi-Yamada J, Saito S, Hoshi Y, Yamada O, Mizoguchi H and Yamada H: Cytostatic concentrations of anticancer agents do not affect telomerase activity of leukaemic cells in vitro. Eur J Cancer 35: 309-315, 1999.
34. Tentori L, Balduzzi A, Portarena I, Levati L, Vernole P, Gold B, Bonmassar E and Graziani G: Poly (ADP-ribose) polymerase inhibitor increases apoptosis and reduces necrosis induced by a DNA minor groove binding methyl sulfonate ester. Cell Death Differ 8: 817-828, 2001.
35. Yamada O, Motoji T and Mizoguchi H: Up-regulation of telomerase activity in human lymphocytes. Biochim Biophys Acta 12: 260-266, 1996.
36. Takahashi A: Pre-irradiation at a low dose-rate blunted p53 response. J Radiat Res 43: 1-9, 2002.
37. Neuhof D, Ruess A, Wenz F and Weber KJ: Induction of telomerase activity by irradiation in human lymphoblasts. Radiat Res 155: 693-697, 2001.
38. Iwamoto KS, Mizuno T, Ito T, Tsuyama N, Kyoizumi S and Seyama T: Gain-of-function p53 mutations enhance alteration of the T-cell receptor following X-irradiation, independently of the cell cycle and cell survival. Cancer Res 56: 3862-3865, 1996.
39. Jonathan EC, Bernhard EJ and McKenna WG: How does radiation kill cells? Curr Opin Chem Biol 3: 77-83, 1999.
40. Filippovich IV, Sorokina NI, Lisbona A, Cherel M and Chatal JF: Radiation-induced apoptosis in human myeloma cell line increases BCL-2/BAX dimer formation and does not result in BAX/BAX homodimerization. Int J Cancer 92: 651-660, 2001.
41. Naume B, Borgen E, Nesland JM, Beiske K, Gilen E, Renolen A, Ravnas G, Qvist H, Karesen R and Kvalheim G: Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation. Int J Cancer 78: 556-560, 1998.